Paradia, Dorotea C.
HRN: 03-48-74 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/03/2025
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
03/03/2025
03/10/2025
IV
250mg
OD
Pneumonia
Waiting Final Action
Indication: Prophylaxis Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes